Gottron's sign

From WikiMD's WELLNESSPEDIA

File:Dermatomyositis2.jpg

Gottron's sign is a clinical dermatological manifestation primarily associated with Dermatomyositis, a type of inflammatory myopathy. It is characterized by the presence of flat-topped, violaceous papules and plaques over the extensor surfaces of joints, particularly the knuckles. This sign is considered pathognomonic for dermatomyositis, meaning it is specifically indicative of the disease and aids significantly in its diagnosis.

Presentation[edit]

Gottron's sign manifests as erythematous to violaceous, flat-topped papules and plaques. These lesions are typically found over the dorsal aspect of finger joints (metacarpophalangeal and interphalangeal joints), elbows, knees, and sometimes the toes. The skin changes may be accompanied by pruritus (itching) but are more often painless. Over time, these lesions can become hyperkeratotic, developing a scale or crust.

Pathophysiology[edit]

The exact pathophysiological mechanism behind Gottron's sign is not fully understood. However, it is believed to be related to the immune-mediated attack inherent in dermatomyositis, which targets both muscle and skin. The inflammation leads to vascular changes and subsequent dermal and epidermal damage, manifesting as the characteristic lesions of Gottron's sign.

Diagnosis[edit]

The presence of Gottron's sign is highly suggestive of dermatomyositis, especially when accompanied by other clinical features of the disease, such as muscle weakness, heliotrope rash (a purplish rash on the eyelids), and elevated muscle enzymes in the blood. A definitive diagnosis usually requires a combination of clinical presentation, laboratory tests (including muscle enzymes and specific autoantibodies), electromyography, and muscle biopsy.

Treatment[edit]

Treatment of Gottron's sign involves addressing the underlying dermatomyositis. This may include systemic corticosteroids, immunosuppressive agents, and antimalarial drugs for skin involvement. Topical therapies, such as corticosteroids and calcineurin inhibitors, may also be used to manage the skin lesions directly.

Prognosis[edit]

The prognosis for individuals with Gottron's sign, as part of dermatomyositis, varies. Early diagnosis and treatment can improve outcomes, but the disease can be chronic and relapsing. Complications of dermatomyositis, including lung involvement and increased cancer risk, can affect prognosis.

See Also[edit]


Sponsored Health Resource

W8MD weight loss success

W8MD Weight Loss, Sleep & MedSpa

Looking for physician-supervised weight loss, semaglutide, tirzepatide, or GLP-1 receptor agonist options? W8MD helps eligible patients in New York City, Brooklyn, New Jersey, Connecticut, Pennsylvania, Delaware, and greater Philadelphia with medical weight loss, sleep medicine, and long-term maintenance support.

GLP-1 specials: Affordable GLP-1 injections NYC and Philadelphia starting from $29.99/week and up for semaglutide with insurance accepted for qualifying visits, and $45/week and up for tirzepatide with insurance accepted for qualifying visits. Self-pay options start from $59.99/week and up for semaglutide and $69.99/week and up for tirzepatide.

Book a W8MD appointment · View GLP-1 specials

Paid promotional message. Eligibility, pricing, insurance coverage, medication availability, and results vary. Medical evaluation required.

Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.

Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.